🔎 Trials Near Me

Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › North Carolina › Durham

Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma Durham, NC keessatti

Qorannoo 14 Diffuse Large B-Cell Lymphoma f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Namoota walitti qabaa jiraSadarkaa 2
  • Duke Blood Cancer Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06500273

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Namoota walitti qabaa jiraSadarkaa 2
  • University of North Carolina Medical Center ( Site 0136), Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06890884

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • Duke University Medical Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06091865

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · Miili 10 fagaatti
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Duke University Medical Center - Division of Hematologic Malignancies, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06116110

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • Duke Cancer Institute, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University Medical Center - Division of Hematologic Malignancies, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Duke University Medical Center, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05131022

Registry of Older Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Miili 10 fagaatti
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT01137825

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

Namoota walitti qabaa jiraSadarkaa 1
  • Duke Univerisity, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT04775745

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Miili 10 fagaatti
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 27-Onk-2025 · NCT01137643

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • University of North Carolina, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2025 · NCT05780034

A Study of NX-1607 in Adults With Advanced Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • University of North Carolina, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT05107674

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Namoota walitti qabaa jiraSadarkaa 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Ful-2024 · NCT06238648

Qorannoo Diffuse Large B-Cell Lymphoma magaalota biroo keessatti

Qorannoo biroo Durham keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.